BTG2 and myocardial infarction: Inhibition of BTG2 has been shown to decrease pro-inflammatory markers and myocardial injury indicators, improve heart function, slow myocardial damage progression, inhibit apoptosis, and exert cardioprotective effects in MI rats (29).